Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 1998
Immunodominance across HLA polymorphism: implications for cancer immunotherapyC J Kim, D R Parkinson, F MarincolaClinical Pharmacy|January 1, 1984
Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapyR A Smaglia, D R Parkinson, C D TaylorJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
Altered natural killer cell biology in C57BL/6 mice after leukemogenic split-dose irradiationD R Parkinson, R P Brightman, S D WaksalOncology (Williston Park, N.Y.)|December 1, 1993
Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcomaJ M Pluda, D R Parkinson, E Feigal, et al.Nature|January 6, 1985
Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patientsT G Krontiris, N A DiMartino, M Colb, et al.International Journal of Immunopharmacology|January 1, 1983
The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysisM Golden, R A Dempsey, J W Mier, et al.Investigational New Drugs|January 1, 1996
Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI)M Smith, P T HoPeptide Research|September 1, 1994
A practical synthesis of optically pure and fully protected L-gamma-carboxyglutamic acid derivatives and its application in peptide synthesisP T Ho, K NguJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1980
Immunologic abnormalities in HRS/J mice. I. Specific deficit in T lymphocyte helper function in a mutant mouseP J Morrissey, D R Parkinson, R S Schwartz, et al.American Journal of Clinical Oncology|April 1, 1993
Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology GroupA Chang, M Hunt, D R Parkinson, et al.Pageof 10